The Penicillin G Benzathine Suspensi, cataloged under National Stock Number 6505-01-156-1722, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 8 specifications, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-156-1722 |
| Item Name | Penicillin G Benzathine Suspensi |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Therapeutic Equivalent | BICILLIN L-A BY WYETH LABORATORIES |
| Administration | INTRAMUSCULAR |
| Primary Container Content Quantity | 4.000 MILLILITERS |
| Supplementary Features | NOTES: G;F |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | SYRINGE-NEEDLE UNIT |
| Active Medicament Medicinal Strength | 2400000.000 USP UNITS PENICILLIN G BENZATHINE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Reference | Meaning |
|---|---|
| BICILLIN LA | 5/9 Secondary reference King Pharmaceuticals, Inc. Dba Pfizer |
| NDC60793-0792-10 | 5/9 Secondary reference King Pharmaceuticals, Inc. Dba Pfizer |
| NDC60793-0702-10 | 3/2 Design control — primary reference U.S. Government activity |
NSN 6505-01-156-1722 is a Penicillin G Benzathine Suspensi, classified under FSC 6505, Drugs and Biologicals. Status: active.
1 possible match (shared part number, not a government interchangeability claim): 6505-01-562-3649. Verify interchangeability with system specifications before substitution.
Key specifications for 6505-01-156-1722: Therapeutic Equivalent: BICILLIN L-A BY WYETH LABORATORIES; Administration: INTRAMUSCULAR; Primary Container Content Quantity: 4.000 MILLILITERS; Supplementary Features: NOTES: G;F. 8 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.